KMD Bioscience Co., Ltd. was established in Tianjin, China in 2014. The founder team has many years of experiences in human drug research and development. KMD Bioscience takes research & development as the foundation of its value and focuses on providing high-quality products and drug-antibody discovery services for global scientists, research institutes and pharmaceutical companies. As a high-tech enterprise in China, KMD Bioscience has successfully obtained the ISO9001:2015 quality management system certification and national patent pilot laboratory honor. At present, the company has more than 30 patents and 2 registered trademarks. KMD Bioscience provides more than 800+ technical service consulting, custom service design and project delivery for research institutes, hospitals, pharmaceutical companies and biological companies worldwide every year.
At the beginning of its establishment, KMD Bioscience started from the phage display technology platform to provide high-quality antibody discovery services, and gradually established stable cell line construction and screening, natural protein extraction and fermentation, and recombinant protein custom expression services, a multi-species antibody discovery platform. Based on the above-mentioned major R&D platforms, KMD Bioscience has successfully developed many related reagents such as recombinant proteins, antibodies, antibody drug similars, industrial enzymes, and diagnostic raw materials for scientific research and new drug discovery.